e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Hyun Woo Lee, Jaeyoung Cho, Nakwon Kwak, Inpyeong Hwang, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Young Whan Kim, Sun Mi Choi
Source:
ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Journal Issue:
July
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hyun Woo Lee, Jaeyoung Cho, Nakwon Kwak, Inpyeong Hwang, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Young Whan Kim, Sun Mi Choi. Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?. ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Do cavitating non-small cell lung cancer patients have a more aggressive disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Follow up of surgically treated non small cell lung cancer patients: which modalities?
Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment
Year: 2008
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases
Source: ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases
Year: 2021
Effectiveness of PET scan in postoperative long term follow up of patients with nonsmall cell lung cancer
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation?
Source: Eur Respir J 2004; 24: Suppl. 48, 522s
Year: 2004
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Regular follow-up for patients irradiated for early stage nonsmall-cell lung cancer too!
Source: Eur Respir J 2002; 20: 1065-1066
Year: 2002
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1357-1364
Year: 2013
Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Clinical features of nonsmall cell lung cancer cases
Source: Eur Respir J 2002; 20: Suppl. 38, 75s
Year: 2002
Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC)
Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors
Year: 2008
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept